Uemoto Y, A Lin CC, Wang B, Ye D, et al. Corrigendum to "Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations" [619 1 (2025) 217668 1-13]. Cancer Lett 2025;626:217782.
PMID: 40367673